Dr. Teresa Hillier is an endocrinologist who holds dual appointments at CHR Northwest and CHR Hawaii. Her research focuses on how modifiable risk factors earlier in life can affect future risk of endocrine diseases across lifespans, including gestational diabetes, obesity, metabolic syndrome, type 2 diabetes, and osteoporosis.
Dr. Hiller has more than 10 years’ experience as the principal investigator of multicenter trials. She is principal investigator of the Study of Osteoporotic Fractures (SOF), an ongoing, nearly 30-year U.S. multicenter prospective cohort study of 9,704 women ages 65 and older that is examining risk factors for osteoporosis as well as characteristics of exceptional aging among post-menopausal women. She also directs two studies associated with SOF, one that examines health outcomes relating to hip fracture and one that compares health outcomes among women who are caregivers.
Dr. Hillier is also active in diabetes and obesity research. She currently directs a study partnering with both the KPNW and KP-Hawaii regions to determine whether early screening and treatment of gestational diabetes among high-risk obese women reduces complications for mother and baby.
She received her MD from Oregon Health & Science University in 1990, followed by an MS in epidemiology from the University of Virginia in 1998. She completed her residency in internal medicine at the Providence Medical Center in Portland and her endocrinology fellowship at the University of Virginia.